NCT03127644 - ZS Ph2/3 Dose-response Study in Japan | Biotech Hunter

Enrollment

103

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions

Hyperkalemia

Interventions

DRUG

Sodium Zirconium Cyclosilicate (ZS) 5g

Suspension administered 5g orally three times daily for 48 hours.

DRUG

Sodium Zirconium Cyclosilicate (ZS) 10g

Suspension administered 10g orally three times daily for 48 hours.

DRUG

Placebo

Placebo suspension administered orally placebo three times daily for 48 hours.

Trial Locations (25)

260-8712

Research Site, Chiba

263-0043

Research Site, Chiba

348-8505

Research Site, Hanyu-shi

311-3193

Research Site, Higashiibaraki-gun

312-0057

Research Site, Hitachi-Naka

396-8555

Research Site, Ina-shi

892-8580

Research Site, Kagoshima

920-0293

Research Site, Kahoku-gun

247-8533

Research Site, Kamakura-shi

920-8650

Research Site, Kanazawa

486-8510

Research Site, Kasugai-shi

586-8521

Research Site, Kawachinagano-shi

216-8511

Research Site, Kawasaki-shi

802-0001

Research Site, Kitakyushu-shi

306-0041

Research Site, Koga-shi

525-8585

Research Site, Kusatsu-shi

271-0077

Research Site, Matsudo-shi

791-8026

Research Site, Matsuyama

457-8511

Research Site, Nagoya

311-0113

Research Site, Naka

856-8562

Research Site, Omura-shi

901-0493

Research Site, Shimajiri-gun

421-0117

Research Site, Shizuoka

581-0011

Research Site, Yakushi

284-0027

Research Site, Yotsukaido-shi